1. Home
  2. ABCL vs VSTS Comparison

ABCL vs VSTS Comparison

Compare ABCL & VSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$9.44

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Vestis Corporation

VSTS

Vestis Corporation

HOLD

Current Price

$13.80

Market Cap

1.9B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
VSTS
Founded
2012
1936
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
ABCL
VSTS
Price
$9.44
$13.80
Analyst Decision
Strong Buy
Sell
Analyst Count
5
4
Target Price
$8.40
$5.88
AVG Volume (30 Days)
6.1M
1.2M
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
N/A
EPS
N/A
N/A
Revenue
$75,128,000.00
$2,734,839,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$21.85
$1.67
P/E Ratio
N/A
N/A
Revenue Growth
160.56
N/A
52 Week Low
$2.75
$3.98
52 Week High
$10.01
$16.90

Technical Indicators

Market Signals
Indicator
ABCL
VSTS
Relative Strength Index (RSI) 77.04 40.18
Support Level $3.38 $13.40
Resistance Level N/A $15.06
Average True Range (ATR) 0.51 0.50
MACD 0.29 -0.25
Stochastic Oscillator 87.97 7.25

Price Performance

Historical Comparison
ABCL
VSTS

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

Share on Social Networks: